99mTc-cAbVCAM1-5

N/A

Report date: 2025/09/24 16:01:11

Base Information

Drug Name99mTc-cAbVCAM1-5

Drug Alias NameATHENA99mTccAbVCAM1‐599mTc-cAbVCAM1-5

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody) +[5]

Mechanisms of ActionVascular cell adhesion molecule 1 modulators

TargetsVascular cell adhesion molecule 1

Therapy Area/IndicationsAtherosclerosisCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedico-Economic Evaluation Unit , University Hospital, Grenoble

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Grenoble

Inactive CompaniesN/A

Active IndicationsAtherosclerosis

Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A